AGF Investments Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

AGF Investments Inc’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,666	Closed	-$1.02M	–	711
2021 Q4	$1.02M	Buy	4,666 +870	+23%	+$169K	0.01%	425
2021 Q3	$689K	Buy	3,796 +149	+4%	+$29.1K	0.01%	449
2021 Q2	$735K	Buy	3,647 +154	+4%	+$32.2K	0.01%	453
2021 Q1	$751K	Sell	3,493 -3,476	-50%	-$763K	0.01%	447
2020 Q4	$1.65M	Buy	6,969 +1,092	+19%	+$251K	0.01%	327
2020 Q3	$1.6M	Buy	5,877 +3,073	+110%	+$848K	0.02%	311
2020 Q2	$814K	Sell	2,804 -147	-5%	-$39.9K	0.01%	378
2020 Q1	$702K	Buy	+2,951	New	+$677K	0.01%	362

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AGF Investments Inc's VRTX Position: Q1 2022 in Review

AGF Investments Inc sold out of Vertex Pharmaceuticals (VRTX) in Q1 2022, closing a stake of 4,666 shares — an estimated $1.02M sold.

AGF Investments Inc first reported a position in VRTX in Q1 2020 and held it in 8 quarters. The position peaked at $1.65M in Q4 2020. 1,071 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

AGF Investments Inc reported no remaining Vertex Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
AGF Investments Inc sold 4,666 Vertex Pharmaceuticals shares in Q1 2022, an estimated $1.02M.
AGF Investments Inc first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 8 quarters.
AGF Investments Inc's Vertex Pharmaceuticals position peaked at $1.65M in Q4 2020.
1,071 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.